January 20, 2023

Lance Hill in PharmExec: a bright future for medical affairs

Within3’s CEO shares how technology offers a tech-enabled way forward.
tech enabled future of medical affairs

Within3 CEO Lance Hill recently presented a compelling vision of the tech-enabled future of medical affairs: one where processes and people are tech-enabled to achieve better results.

After Hill’s talk, PharmExec grabbed a few minutes to hear more about the changing role of medical affairs, what data insights medical affairs may need and how AI, analytics, and technology, like an insights management platform, can help in the medical affairs role.

There’s a tremendous amount of interest in really understanding artificial intelligence, and how artificial intelligence is directly impacting this idea of bringing in insights from the field – unstructured text and notes, basically – and being able to turn them into action very quickly.

For medical affairs teams, what is the impact of being able to act in response to new information? Organizations may be able to shorten development timelines, avoid delays across all stages of the product life cycle, and ultimately get treatments to patients faster.

Get more insights in this short video.

Related Posts:

pharma industry lessons learned

Within3 in European Pharmaceutical Manufacturer: looking back, forging ahead

Our experts weigh in on more trends and predictions for 2023.
orphan drug challenges

Within3 in MedCity News

Advanced technology can help the pharmaceutical industry work through the inherent challenges of orphan drug development.
tech talent for healthcare

Within3 CTO Jason Smith in Healthcare IT Today

Healthcare technology companies are focusing on how to attract and retain tech talent.